21 CFR § 14.30 - Chairperson of an advisory committee.

---
identifier: "/us/cfr/t21/s14.30"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 14.30 - Chairperson of an advisory committee."
title_number: 21
title_name: "Food and Drugs"
section_number: "14.30"
section_name: "Chairperson of an advisory committee."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL"
part_number: "14"
part_name: "PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "5 U.S.C. 1001  15 U.S.C. 1451-1461; 21 U.S.C. 41-50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264, 284m, 284m-1; Pub. L. 107-109, 115 Stat. 1419."
regulatory_source: "44 FR 22351, Apr. 13, 1979, unless otherwise noted."
cfr_part: "14"
---


# 14.30 Chairperson of an advisory committee.

(a) The advisory committee Chairperson has the authority to conduct hearings and meetings, including the authority to adjourn a hearing or meeting if the Chairperson determines that adjournment is in the public interest, to discontinue discussion of a matter, to conclude the open portion of a meeting, or to take any other action to further a fair and expeditious hearing or meeting.

(b) If the Chairperson is not a full-time employee of FDA, the Designated Federal Officer or other designated agency employee, or alternate, is to be the *designated Federal employee* who is assigned to the advisory committee. The designated Federal employee is also authorized to adjourn a hearing or meeting if the employee determines adjournment to be in the public interest.